BP PLC
Change company Symbol lookup
Select an option...
BP BP PLC
SSNT SilverSun Technologies Inc
MDLZ Mondelez International Inc
FE FirstEnergy Corp
CADE Cadence Bancorp
SCHD Schwab U.S. Dividend Equity ETF™
ARKK ARK Innovation ETF
URANF International Prospect Ventures Ltd
QSR Restaurant Brands International Inc
STAF Staffing 360 Solutions Inc
Go

Energy : Oil, Gas & Consumable Fuels | Large Cap Value
Based in United Kingdom
Company profile

BP p.l.c. is engaged in the global energy business with operations in Europe, North and South America, Australasia, Asia and Africa. The Company provides customers with fuel for transport, energy for heat and light, power for industry, and the petrochemicals products used to make everyday items such as paints, clothes and packaging. The Company's segments include Upstream, Downstream, Rosneft, and Other businesses and corporate. The Upstream segment is responsible for its activities in oil and natural gas exploration, field development and production. The Downstream segment has global marketing and manufacturing operations, and include the fuels, lubricants and petrochemicals business of the Company. Rosneft is the Company's Russian refining business that owns and operates approximately 13 refineries in Russia, and holds stakes in three refineries in Germany, one in India and one in Belarus.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$24.34
Day's Change
-0.62 (-2.48%)
Bid
--
Ask
--
B/A Size
--
Day's High
24.78
Day's Low
24.31
Volume
(Average)
Volume:
14,872,771

10-day average volume:
16,066,670
14,872,771

UPDATE: Bionano Genomics' stock rally result of awareness push in 2019 and 2020 about its genomic technology: analyst

9:47 am ET January 22, 2021 (MarketWatch)
Print

Shares of Bionano Genomics Inc. (BNGO) gained 10.3% in premarket trading on Friday following a week of heavy trading on the stock. The company's stock price has tripled since the start of the year, closing at $8.27 on Jan. 21, compared to $3.08 on Dec. 31. According to Maxim Group's Jason McCarthy, the increased investor interest in Bionano stems from two years of work to raise awareness of its Saphyr optical genome mapping system and a five-day virtual symposium in January that focused on the technology. "Awareness, adoption, and messaging in 2019 and 2020 culminated with a cytogenetics symposium that has opened the eyes of the genomics world to Saphyr, in our view," he wrote. The Saphyr technology is allowed for research-use only in the U.S. The company launched two public offerings in the last week; the first raised $101.8 million in gross proceeds, the second aims to raise $200 million. The company lost nearly [l:$30 million on sales of $4.5 million|https://www.marketwatch.com/story/bionano-genomics-to-sell-more-shares-stock-falls-2021-01-19?mod=mw_quote_news|NEW] in the first nine months of 2020. Bionano's stock has soared 583.4% over the past, with most of the rally occurring in January. The S&P 500 is up 16.0% over the past 12 months.

-Jaimy Lee; 415-439-6400; AskNewswires@dowjones.com

	

(END) Dow Jones Newswires

January 22, 2021 09:47 ET (14:47 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.